Newsroom

Agilent Acquires ProZyme

"Agilent has entered into an agreement to acquire ProZyme, Inc., a leading provider of glycan analysis reagents, kits and standards. This acquisition will expand Agilent’s portfolio of biopharma consumables in the fast-growing glycan market." Learn more

Twitter

More Twitter